Janos Paloczi
Janos Paloczi
LSU Health Science Center
Verified email at
Cited by
Cited by
MicroRNA-25-dependent up-regulation of NADPH oxidase 4 (NOX4) mediates hypercholesterolemia-induced oxidative/nitrative stress and subsequent dysfunction in the heart
ZV Varga, K Kupai, G Szűcs, R Gáspár, J Pálóczi, N Faragó, Á Zvara, ...
Journal of molecular and cellular cardiology 62, 111-121, 2013
PARP inhibition protects against alcoholic and non-alcoholic steatohepatitis
P Mukhopadhyay, B Horváth, M Rajesh, ZV Varga, K Gariani, D Ryu, ...
Journal of hepatology 66 (3), 589-600, 2017
Alcohol misuse and kidney injury: epidemiological evidence and potential mechanisms
ZV Varga, C Matyas, J Paloczi, P Pacher
Alcohol research: current reviews 38 (2), 283, 2017
Neuroprotection in oxidative stress-related neurodegenerative diseases: role of endocannabinoid system modulation
J Paloczi, ZV Varga, G Hasko, P Pacher
Antioxidants & redox signaling 29 (1), 75-108, 2018
Macrophage P2X4 receptors augment bacterial killing and protect against sepsis
B Csóka, ZH Németh, I Szabó, DL Davies, ZV Varga, J Pálóczi, S Falzoni, ...
JCI insight 3 (11), 2018
β‐Caryophyllene protects against alcoholic steatohepatitis by attenuating inflammation and metabolic dysregulation in mice
ZV Varga, C Matyas, K Erdelyi, R Cinar, D Nieri, A Chicca, BT Nemeth, ...
British journal of pharmacology 175 (2), 320-334, 2018
Pepcan-12 (RVD-hemopressin) is a CB2 receptor positive allosteric modulator constitutively secreted by adrenals and in liver upon tissue damage
V Petrucci, A Chicca, S Glasmacher, J Paloczi, Z Cao, P Pacher, J Gertsch
Scientific reports 7 (1), 9560, 2017
Chronic plus binge ethanol feeding induces myocardial oxidative stress, mitochondrial and cardiovascular dysfunction, and steatosis
C Matyas, ZV Varga, P Mukhopadhyay, J Paloczi, T Lajtos, K Erdelyi, ...
American Journal of Physiology-Heart and Circulatory Physiology 310 (11 …, 2016
Discovery of a NAPE-PLD inhibitor that modulates emotional behavior in mice
ED Mock, M Mustafa, O Gunduz-Cinar, R Cinar, GN Petrie, V Kantae, X Di, ...
Nature chemical biology 16 (6), 667-675, 2020
PCSK9 inhibition as a novel therapeutic target for alcoholic liver disease
JS Lee, P Mukhopadhyay, C Matyas, E Trojnar, J Paloczi, YR Yang, ...
Scientific reports 9 (1), 17167, 2019
Cannabinoid‐1 receptor deletion in podocytes mitigates both glomerular and tubular dysfunction in a mouse model of diabetic nephropathy
T Jourdan, JK Park, ZV Varga, J Pálóczi, NJ Coffey, AZ Rosenberg, ...
Diabetes, Obesity and Metabolism 20 (3), 698-708, 2018
Bile acid–activated macrophages promote biliary epithelial cell proliferation through integrin αvβ6 upregulation following liver injury
A Guillot, L Guerri, D Feng, SJ Kim, YA Ahmed, J Paloczi, Y He, ...
The Journal of clinical investigation 131 (9), 2021
Preconditioning protects the heart in a prolonged uremic condition
GF Kocsis, M Sárközy, P Bencsik, M Pipicz, ZV Varga, J Pálóczi, ...
American Journal of Physiology-Heart and Circulatory Physiology 303 (10 …, 2012
Interplay of Liver–Heart Inflammatory Axis and Cannabinoid 2 Receptor Signaling in an Experimental Model of Hepatic Cardiomyopathy
C Matyas, K Erdelyi, E Trojnar, S Zhao, ZV Varga, J Paloczi, ...
Hepatology 71 (4), 1391-1407, 2020
Activation of PPARβ/δ protects cardiac myocytes from oxidative stress-induced apoptosis by suppressing generation of reactive oxygen/nitrogen species and expression of matrix …
E Barlaka, A Görbe, R Gáspár, J Pálóczi, P Ferdinandy, A Lazou
Pharmacological research 95, 102-110, 2015
Disruption of R enal A rginine M etabolism P romotes K idney I njury in H epatorenal S yndrome in M ice
ZV Varga, K Erdelyi, J Paloczi, R Cinar, ZK Zsengeller, T Jourdan, ...
Hepatology 68 (4), 1519-1533, 2018
Cholesterol-enriched diet inhibits cardioprotection by ATP-sensitive K+ channel activators cromakalim and diazoxide
C Csonka, K Kupai, P Bencsik, A Görbe, J Pálóczi, Á Zvara, LG Puskás, ...
American Journal of Physiology-Heart and Circulatory Physiology 306 (3 …, 2014
Moderate inhibition of myocardial matrix metalloproteinase-2 by ilomastat is cardioprotective
P Bencsik, J Pálóczi, GF Kocsis, J Pipis, I Belecz, ZV Varga, C Csonka, ...
Pharmacological Research 80, 36-42, 2014
Cardioprotection by farnesol: role of the mevalonate pathway
G Szűcs, Z Murlasits, S Török, GF Kocsis, J Pálóczi, A Görbe, T Csont, ...
Cardiovascular drugs and therapy 27, 269-277, 2013
MMP activity detection in zymograms
P Bencsik, M Bartekova, A Görbe, K Kiss, J Pálóczi, J Radosinska, ...
Zymography: Methods and Protocols, 53-70, 2017
The system can't perform the operation now. Try again later.
Articles 1–20